Corbus Pharmaceuticals Holdings, Inc. (CRBP)

CRBP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.9	17.2	13.72	17	25.01	85.43
Short-Term Investments	113.89	131.86	7.18	42.19	72.64	-
Cash & Short-Term Investments	132.79	149.06	20.91	59.2	97.65	85.43
Cash Growth	10.56%	613.01%	-64.68%	-39.38%	14.30%	169.09%
Accounts Receivable	-	-	-	-	-	1.62
Other Receivables	1.1	-	-	-	-	0.96
Receivables	1.1	-	-	-	-	2.58
Prepaid Expenses	3.19	3.63	2.45	0.79	2.37	3.71
Restricted Cash	0.29	0.29	0.19	0.19	0.19	0.35
Total Current Assets	137.36	152.98	23.55	60.18	100.2	92.07
Property, Plant & Equipment	2.19	2.52	4.04	5.5	7	9.32
Other Long-Term Assets	0.39	0.39	0.69	0.63	0.52	0.9
Total Assets	139.93	155.88	28.27	66.31	107.73	102.29
Accounts Payable	4.07	4.79	3.18	2.17	1.78	7.38
Accrued Expenses	5.9	5.43	11.03	6	10.09	22.01
Current Portion of Long-Term Debt	-	-	16.21	3.15	3.86	0.71
Current Portion of Leases	1.65	1.61	1.44	1.28	1.14	1
Other Current Liabilities	-	-	0.04	0.04	0.13	0.8
Total Current Liabilities	11.62	11.82	31.89	12.64	17.01	31.9
Long-Term Debt	-	-	-	15.98	15.64	18.03
Long-Term Leases	1.21	1.63	3.24	4.68	5.96	7.09
Other Long-Term Liabilities	-	-	0.04	0.02	0.02	-
Total Liabilities	12.83	13.45	35.18	33.32	38.62	57.02
Common Stock	0	0	-	0	0	0.01
Additional Paid-In Capital	621	619.29	429.78	425.2	418.9	349.36
Retained Earnings	-493.87	-476.89	-436.68	-392.08	-349.73	-304.09
Comprehensive Income & Other	-0.02	0.04	-0	-0.13	-0.06	-
Shareholders' Equity	127.11	142.43	-6.91	32.99	69.11	45.27
Total Liabilities & Equity	139.93	155.88	28.27	66.31	107.73	102.29
Total Debt	2.86	3.24	20.89	25.09	26.59	26.84
Net Cash (Debt)	129.93	145.82	0.02	34.11	71.06	58.6
Net Cash Growth	26.37%	694295.24%	-99.94%	-52.00%	21.26%	162.73%
Net Cash Per Share	10.93	13.36	0.00	8.18	17.35	22.50
Filing Date Shares Outstanding	12.24	12.23	10.49	4.17	4.17	4.17
Total Common Shares Outstanding	12.23	12.18	4.42	4.17	4.17	3.3
Working Capital	125.74	141.16	-8.35	47.54	83.2	60.18
Book Value Per Share	10.39	11.69	-1.56	7.91	16.56	13.74
Tangible Book Value	127.11	142.43	-6.91	32.99	69.11	45.27
Tangible Book Value Per Share	10.39	11.69	-1.56	7.91	16.56	13.74
Machinery	1.13	1.13	1.2	1.38	1.43	2.25
Leasehold Improvements	3.33	3.33	3.33	3.33	3.33	4.16

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q